erythematosquamous dermatosis: Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1576 |
6. Filter based on genotype QC (FinnGen only) |
1406 |
Control definitions (FinnGen only)
- Control exclude
- L12_URTICARIAERYTHEMA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other erythematous conditions
based on the number of shared cases.
Similar with more cases:
- Urticaria and erythema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10019 | 5986 | 3954 |
| Only index persons | 8013 | 5008 | 3005 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.17 | 0.11 |
| Only index persons | 0.16 | 0.18 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 49.22 | 52.43 | 44.24 |
| Only index persons | 48.59 | 51.84 | 43.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1406 | 916 | 490 |
| Unadjusted period prevalence (%) | 0.29 | 0.33 | 0.22 |
| Median age at first event (years) | 55.67 | 55.16 | 56.61 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1451
- Matched controls
- 14510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L53.8
ICD-10 Finland
Other specified erythematous conditions
164.0
307.7
186
13
L53.9
ICD-10 Finland
Erythematous condition, unspecified
543.2
307.7
919
46
69598
ICD-8 Finland
Erythematous condition, Alii definiti
+∞
113.0
107
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
106.2
284
712
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.9
71.2
457
1985
L50.9
ICD-10 Finland
Urticaria, unspecified
8.7
64.3
83
100
L53.1
ICD-10 Finland
Erythema annulare centrifugum
332.2
62.9
63
*
L50.8
ICD-10 Finland
Other urticaria
23.3
59.1
43
19
69599
ICD-8 Finland
Erythematous condition, Other and unspecified
+∞
58.7
56
*
A46
ICD-10 Finland
Erysipelas
2.9
51.2
296
1193
E0000UV, ,
ATC
2.3
50.5
732
4491
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.3
46.2
196
660
XQ800
NOMESCO Finland
Prick test
3.6
43.0
155
470
D07AC01
ATC
betamethasone; topical
2.2
42.7
617
3710
H02AB06
ATC
prednisolone; systemic
2.1
40.8
773
5121
L53.0
ICD-10 Finland
Toxic erythema
+∞
40.8
39
*
R06AE07
ATC
cetirizine; oral
2.0
37.9
717
4705
T78.4
ICD-10 Finland
Allergy, unspecified
4.0
35.9
105
275
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
35.3
225
942
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
34.0
500
2970
R60.0
ICD-10 Finland
Localized oedema
2.4
29.5
231
1060
L50.0
ICD-10 Finland
Allergic urticaria
6.4
29.3
49
79
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.4
29.1
109
337
D07AB08
ATC
desonide; topical
2.5
26.8
192
845
XQ802
NOMESCO Finland
Epicutan test
3.8
26.0
82
226
S29
ICPC
Skin symptom/complaint other
2.0
25.2
345
1965
E000001, ,
ATC
2.0
25.1
323
1799
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
24.3
565
3805
J01DB01
ATC
cefalexin; oral
2.1
23.3
1214
10325
R06AX27
ATC
desloratadine; oral
1.8
23.1
442
2798
D07AC13
ATC
mometasone; topical
1.8
22.8
446
2839
D07AD01
ATC
clobetasol; topical
2.0
22.4
275
1500
L04AX01
ATC
azathioprine; systemic
3.3
21.9
85
269
L50.3
ICD-10 Finland
Dermatographic urticaria
17.7
21.4
33
19
J01FF01
ATC
clindamycin; systemic
1.8
21.3
417
2647
R50.9
ICD-10 Finland
Fever, unspecified
2.0
20.6
252
1369
M79.6
ICD-10 Finland
Pain in limb
1.7
20.1
672
4928
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
6.9
20.0
31
46
L17
ICPC
Foot/toe symptom/complaint
1.7
19.9
477
3198
L53.3
ICD-10 Finland
Other chronic figurate erythema
+∞
19.8
19
*
H02AB07
ATC
prednisone; oral
2.0
19.2
220
1167
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
19.2
700
5232
R06AE09
ATC
levocetirizine; oral
2.0
18.4
221
1190
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.1
18.4
193
990
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
18.3
441
2947
S21
ICPC
Skin texture symptom/complaint
1.9
17.6
250
1426
L52
ICD-10 Finland
Erythema nodosum
17.2
17.4
27
16
A02BC02
ATC
pantoprazole; systemic
1.7
17.3
988
8166
D02AE01
ATC
carbamide; topical
2.5
17.2
109
451
XQ848
NOMESCO Finland
Dermatological photography
3.5
17.1
60
178
R42
ICD-10 Finland
Dizziness and giddiness
1.7
16.9
355
2276
R06.0
ICD-10 Finland
Dyspnoea
1.7
16.8
413
2764
L26
ICD-10 Finland
Exfoliative dermatitis
64.1
16.8
19
*
6951D
ICD-9 Finland
Erythematous conditions, Erythema multiforme[ERYTHEMA FIXUM]
+∞
16.7
16
*
134
Kela drug reimbursment
General erythroderma
+∞
16.7
16
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
16.3
149
723
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
15.9
332
2122
UJF32
NOMESCO Finland
Coloscopy
1.7
15.8
383
2549
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
15.8
206
1140
S06
ICPC
Rash localized
2.5
15.4
100
418
D07AA02
ATC
hydrocortisone; topical
1.9
15.3
212
1196
R60.9
ICD-10 Finland
Oedema, unspecified
2.5
15.1
98
410
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
15.0
172
909
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
14.9
169
890
C01CA24
ATC
epinephrine; parenteral
2.4
14.8
102
439
J01MA02
ATC
ciprofloxacin; systemic
1.6
14.5
540
3975
U07
ICPC
Urine symptom/complaint other
2.1
14.4
139
688
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
14.4
330
2156
R03AC02
ATC
salbutamol; inhalant
1.5
14.4
794
6373
S18
ICPC
Laceration/cut
1.5
14.2
674
5229
R06AX22
ATC
ebastine; oral
1.8
14.2
254
1549
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
14.2
511
3730
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
14.1
361
2425
Z3231
NOMESCO Finland
Registered nurse
1.6
14.0
390
2675
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
14.0
705
5536
N02AX02
ATC
tramadol; systemic, rectal
1.5
13.9
598
4537
A07AA09
ATC
vancomycin; oral
5.1
13.9
29
58
A07AA02
ATC
nystatin; oral
2.4
13.7
98
428
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
13.7
201
1153
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
13.6
143
732
D01
ICPC
Abdominal pain/cramps general
1.9
13.6
197
1126
6959X
ICD-9 Finland
Erythematous conditions, Unspecified erythematous condition
+∞
13.6
13
*
A92
ICPC
Allergy/allergic reaction NOS
3.1
13.5
58
195
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
13.4
189
1070
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.6
13.3
76
299
Z71.8
ICD-10 Finland
Other specified counselling
1.6
13.2
493
3616
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
13.1
76
301
X58
ICD-10 Finland
Exposure to other specified factors
1.8
13.1
221
1323
J02AC01
ATC
fluconazole; systemic
1.5
13.0
562
4250
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.0
12.8
57
196
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
12.7
169
939
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
12.7
334
2254
P01BA02
ATC
hydroxychloroquine; oral
2.1
12.7
131
666
M25.5
ICD-10 Finland
Pain in joint
1.5
12.5
486
3585
R51.80
ICD-10 Finland
Headache
1.7
12.5
236
1459
E000002, ,
ATC
1.9
12.4
155
842
R02
ICPC
Shortness of breath/dyspnoea
1.8
12.4
207
1234
J01MA12
ATC
levofloxacin; systemic
1.7
12.3
255
1616
E000006, ,
ATC
2.2
12.3
106
502
N30.0
ICD-10 Finland
Acute cystitis
1.7
12.1
265
1702
N02BE01
ATC
paracetamol; systemic, rectal
1.8
12.0
1275
11625
N03AX12
ATC
[U] gabapentin; oral
1.7
11.9
234
1461
D05BB02
ATC
acitretin; oral
3.6
11.9
39
111
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
11.9
142
760
A02BC05
ATC
esomeprazole; systemic
1.5
11.8
564
4330
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
11.8
203
1220
H02AB04
ATC
methylprednisolone; systemic
1.8
11.8
204
1229
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.8
11.7
189
1114
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
11.7
158
881
D06BX01
ATC
metronidazole; topical
1.9
11.7
165
933
A08
ICPC
Swelling
2.2
11.7
98
459
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
11.7
238
1500
J45
ICD-10 Finland
Asthma
1.9
11.6
157
876
N03AX16
ATC
[U] pregabalin
1.6
11.5
322
2200
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
11.4
59
221
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
11.4
193
1155
A69.2
ICD-10 Finland
Lyme disease
2.2
11.3
100
478
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
11.3
110
547
ZYC01
NOMESCO Finland
Remote contact by phone
2.2
11.2
99
473
A02BC01
ATC
omeprazole; systemic
1.6
11.2
367
2595
R01AD09
ATC
mometasone; nasal
1.5
11.2
629
4973
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.4
11.1
40
121
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
11.1
111
557
L71.9
ICD-10 Finland
Rosacea, unspecified
3.0
11.1
48
163
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
11.0
269
1774
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
11.0
43
137
R07.3
ICD-10 Finland
Other chest pain
1.8
11.0
166
958
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
11.0
127
672
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
11.0
267
1760
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.9
319
2197
R03DC03
ATC
montelukast; oral
1.7
10.9
236
1510
U02
ICPC
Urinary frequency/urgency
1.7
10.9
227
1438
E000007, ,
ATC
2.3
10.9
83
374
A01
ICPC
Pain general/multiple sites
1.8
10.8
161
927
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
10.8
276
1843
R4110
NOMESCO Finland
Physiotherapy
1.5
10.6
389
2815
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
10.6
252
1652
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.4
10.5
26
60
SPAT1260
SPAT
Consultation of another employee
1.7
10.5
237
1531
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
10.5
397
2891
69500
ICD-8 Finland
Erythematous condition, Toxic erythema
+∞
10.4
10
*
UKC02
NOMESCO Finland
Cystoscopy
1.7
10.4
202
1254
XX9XE
NOMESCO Finland
Other ultrasound examination
5.5
10.4
20
37
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
3.1
10.4
43
142
M54.5
ICD-10 Finland
Low back pain
1.5
10.4
514
3951
AA1AD
NOMESCO Finland
CT of head and brain
1.5
10.3
397
2901
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
10.2
189
1157
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
10.2
114
597
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
10.1
606
4822
R03BA08
ATC
ciclesonide; inhalant
1.9
10.1
131
720
R74
ICPC
Upper respiratory infection acute
1.5
10.1
450
3385
L14
ICPC
Leg/thigh symptom/complaint
1.9
10.0
127
695
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.2
9.9
38
120
K30
ICD-10 Finland
Functional dyspepsia
1.8
9.9
168
1004
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.6
9.9
55
214
R53
ICD-10 Finland
Malaise and fatigue
1.5
9.8
355
2556
ZXA05
NOMESCO Finland
Left side
1.5
9.8
331
2348
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
9.8
744
6168
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
3.2
9.8
38
121
L20.0
ICD-10 Finland
Besnier prurigo
2.0
9.7
107
556
J01MA14
ATC
moxifloxacin; systemic
1.9
9.7
127
700
A02BC03
ATC
lansoprazole; oral
1.5
9.7
391
2877
Y0999
ICD-8 Finland
Other specific examinations and investigations
13.5
9.7
16
12
J01DA01
ATC
[U] cefalexin
1.4
9.6
837
7098
C03CA01
ATC
furosemide; systemic
1.5
9.6
395
2920
R03BA05
ATC
fluticasone; inhalant
1.6
9.6
256
1723
C07AB07
ATC
bisoprolol; oral
1.4
9.5
647
5249
R01AD08
ATC
fluticasone; nasal
1.5
9.5
376
2755
D11
ICPC
Diarrhoea
1.7
9.5
169
1023
R21
ICPC
Throat symptom/complaint
1.6
9.5
286
1977
A28
ICPC
Limited function/disability NOS
1.6
9.5
252
1692
N03AX09
ATC
lamotrigine; oral
2.3
9.4
71
319
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
9.4
108
571
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
9.3
250
1685
A02BA02
ATC
ranitidine; systemic
1.6
9.3
260
1769
R4120
NOMESCO Finland
Occupational therapy
2.0
9.3
102
531
N05BA04
ATC
oxazepam; oral
1.5
9.2
364
2664
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.9
9.2
41
142
D02AX
ATC
Other emollients and protectives
2.7
9.2
49
187
J01AA02
ATC
doxycycline; systemic
1.5
9.1
1067
9500
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
9.1
136
782
Z3226
NOMESCO Finland
Physiotherapist
1.6
9.1
252
1709
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
9.1
207
1339
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
9.1
577
4616
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
9.0
141
822
E9399
ICD-8 Finland
Complications and failures arising in connection with medical procedures (excluding subsequent adverse effects).
7.1
9.0
21
30
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
9.0
140
815
TQW80
NOMESCO Finland
Local dermatologic skincare
3.0
9.0
40
138
R05
ICPC
Cough
1.5
9.0
352
2571
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
8.9
132
758
J01FA10
ATC
azithromycin; systemic
1.4
8.8
776
6550
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.4
8.8
57
239
A07EA06
ATC
budesonide; oral, local oral
2.4
8.8
57
239
L30
ICD-10 Finland
Other dermatitis
2.9
8.7
41
146
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.4
8.7
57
240
D07XC01
ATC
betamethasone; topical
1.7
8.7
157
955
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
8.7
147
878
R52.9
ICD-10 Finland
Pain, unspecified
1.7
8.6
150
902
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.9
8.6
102
544
KMAK, ,
NOMESCO Finland
1.4
8.6
668
5513
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
8.6
371
2758
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
4.1
8.5
23
57
J01CA04
ATC
amoxicillin; systemic
1.5
8.5
1132
10243
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
8.5
296
2108
A04
ICPC
Weakness/tiredness general
1.6
8.5
225
1509
C84.0
ICD-10 Finland
Mycosis fungoides
20.1
8.5
12
6
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
8.5
51
207
L92.0
ICD-10 Finland
Granuloma annulare
7.4
8.5
19
26
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.4
260
1806
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.3
8.4
30
91
D06
ICPC
Abdominal pain localized other
1.8
8.4
124
712
Z2221
NOMESCO Finland
Medical doctor
1.5
8.4
362
2692
S76
ICPC
Skin infection other
2.1
8.4
79
389
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
8.3
263
1834
L04AD01
ATC
ciclosporin; systemic
3.4
8.2
29
87
B01AB05
ATC
enoxaparin; parenteral
1.4
8.2
417
3192
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.1
8.2
76
372
P29
ICPC
Psychological sympt/compl other
1.9
8.2
107
591
L04AX03
ATC
methotrexate; systemic
1.7
8.2
137
816
L71
ICD-10 Finland
Rosacea
2.7
8.1
43
164
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
33.5
8.1
10
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
8.0
94
500
G44.2
ICD-10 Finland
Tension-type headache
1.6
8.0
191
1248
G47.3
ICD-10 Finland
Sleep apnoea
1.5
8.0
295
2124
ZY010
NOMESCO Finland
Hospital outpatient
2.1
8.0
75
369
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.9
7.9
99
538
J01FA06
ATC
roxithromycin; oral
1.4
7.9
526
4217
L28
ICPC
Limited function/disability (L)
1.5
7.9
262
1846
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
7.8
49
203
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
7.8
170
1087
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
7.8
613
5046
L30.3
ICD-10 Finland
Infective dermatitis
2.4
7.7
51
216
N03AE01
ATC
clonazepam; systemic
2.1
7.7
76
380
R07.0
ICD-10 Finland
Pain in throat
1.9
7.7
97
529
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
7.7
148
916
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.5
7.7
18
40
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
7.6
117
679
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
7.6
115
664
L04AA06
ATC
mycophenolic acid; systemic
3.1
7.6
31
102
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
2.4
7.6
50
212
T78.3
ICD-10 Finland
Angioneurotic oedema
3.8
7.5
22
58
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.0
7.5
75
377
SPAT1263
SPAT
Sampling
1.4
7.5
540
4372
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
7.5
92
497
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
7.5
105
592
N05BA01
ATC
diazepam; systemic, rectal
1.6
7.5
174
1129
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
7.5
124
736
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
7.5
132
798
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
7.4
205
1385
H03AA01
ATC
levothyroxine sodium; systemic
1.5
7.4
318
2353
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.4
548
4454
M03BX02
ATC
tizanidine; oral
1.4
7.4
821
7105
S01
ICPC
Pain/tenderness of skin
2.1
7.4
69
338
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
7.4
261
1859
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.0
7.4
32
109
ZXY60, ,
SPAT
13.4
7.4
12
9
R03AC03
ATC
terbutaline; inhalant
1.6
7.4
184
1216
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.4
7.3
49
209
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
7.3
72
360
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.8
7.3
36
132
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.1
7.3
70
347
69590
ICD-8 Finland
Erythematous condition, Erythema chronicum migrans
+∞
7.3
7
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.3
573
4702
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
7.3
92
503
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
7.3
187
1244
R04
ICPC
Breathing problem other
2.2
7.2
60
281
S08
ICPC
Skin colour change
2.0
7.2
80
418
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
7.2
131
798
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
7.2
497
3992
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
7.2
111
646
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
7.2
162
1045
A03
ICPC
Fever
1.5
7.2
225
1565
L93.1
ICD-10 Finland
Subacute cutaneous lupus erythematosus
30.2
7.2
9
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
7.1
522
4231
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
7.1
95
528
L12
ICPC
Hand/finger symptom/complaint
1.5
7.1
239
1685
J05AB11
ATC
valaciclovir; oral
1.6
7.1
199
1349
J20
ICD-10 Finland
Acute bronchitis
1.7
7.1
140
872
R83
ICPC
Respiratory infection other
1.4
7.1
328
2461
R03BA01
ATC
beclometasone; inhalant
1.6
7.1
180
1195
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
7.0
56
258
M79.3
ICD-10 Finland
Panniculitis, unspecified
10.1
7.0
13
13
H01
ICPC
Ear pain/earache
1.6
7.0
159
1026
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
7.0
171
1124
ZXA10
NOMESCO Finland
Bilateral
1.5
7.0
238
1684
N05BB01
ATC
hydroxyzine; systemic
1.9
6.9
81
431
R11
ICD-10 Finland
Nausea and vomiting
1.7
6.9
124
752
C08CA05
ATC
nifedipine; systemic
2.0
6.9
77
403
S16
ICPC
Bruise/contusion
2.4
6.9
46
196
R09.1
ICD-10 Finland
Pleurisy
2.9
6.8
31
109
R01AD58
ATC
fluticasone, combinations; nasal
1.4
6.8
318
2388
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.8
327
2469
N06AX21
ATC
duloxetine; oral
1.6
6.8
166
1091
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
6.8
82
442
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.8
531
4343
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.1
6.8
61
296
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
6.7
93
523
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
6.7
68
345
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.7
6.7
137
862
N06AB10
ATC
escitalopram; oral
1.5
6.7
261
1897
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
6.5
6.6
16
25
A29
ICPC
General symptom/complaint other
1.5
6.6
188
1278
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.7
6.6
34
128
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
6.6
169
1123
DHB50
NOMESCO Finland
Turbinoplasty
2.6
6.6
37
146
HA1AA
NOMESCO Finland
X-ray mammography
1.7
6.5
121
741
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
6.5
117
710
L01BA01
ATC
methotrexate; systemic
2.2
6.5
50
227
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
6.5
129
804
N06AX16
ATC
venlafaxine; oral
1.5
6.5
189
1291
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
6.5
327
2485
A23
ICPC
Risk factor NOS
1.6
6.5
134
844
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
6.5
295
2202
M77.1
ICD-10 Finland
Lateral epicondylitis
1.8
6.5
99
574
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
6.5
51
234
TAB00
NOMESCO Finland
Lumbar puncture
2.0
6.5
65
328
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
6.5
242
1741
K92.1
ICD-10 Finland
Melaena
2.0
6.5
71
370
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.9
6.5
78
420
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.6
6.5
37
147
R06AX13
ATC
loratadine; oral
1.5
6.5
191
1310
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
6.5
131
822
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
6.5
262
1916
R96
ICPC
Asthma
1.6
6.5
135
854
R19.4
ICD-10 Finland
Change in bowel habit
2.4
6.5
44
190
J01FA09
ATC
clarithromycin; systemic
1.4
6.4
397
3122
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
70.2
6.4
7
*
ZYY97, ,
SPAT
70.2
6.4
7
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.2
6.4
52
242
C10AC01
ATC
colestyramine; oral
2.4
6.4
41
172
WZC30, ,
SPAT
1.7
6.4
119
730
R30.0
ICD-10 Finland
Dysuria
2.1
6.4
60
296
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
6.4
92
525
J01CE08
ATC
benzathine benzylpenicillin; parenteral
4.1
6.4
17
42
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
6.4
688
5882
K96
ICPC
Haemorrhoids
2.3
6.3
45
198
S89.8
ICD-10 Finland
Other specified injuries of lower leg
6.0
6.3
16
27
N06AX11
ATC
mirtazapine; oral
1.4
6.3
444
3565
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.3
239
1726
S70
ICPC
Herpes zoster
2.4
6.3
42
180
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
6.3
379
2970
69592
ICD-8 Finland
Erythematous condition, Erythrodermia exfoliativa NUD
+∞
6.3
6
*
ZXY49, ,
SPAT
+∞
6.3
6
*
6958X
ICD-9 Finland
Erythematous conditions, Other specified erythematous conditions[CASUS ERYTHEMATODES ALIA DEFINITA]
+∞
6.3
6
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.8
6.2
30
109
UJG02
NOMESCO Finland
Proctoscopy
2.6
6.2
34
132
P01
ICPC
Feeling anxious/nervous/tense
1.6
6.2
156
1031
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
2.1
6.2
55
265
P19
ICPC
Drug abuse
7.1
6.2
14
20
N03AG01
ATC
valproic acid; systemic, rectal
1.9
6.2
78
426
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
6.2
89
507
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
6.2
412
3276
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
6.2
137
879
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.5
6.2
20
57
L04AA01
ATC
[U] ciclosporin
3.5
6.2
20
57
N48.1
ICD-10 Finland
Balanoposthitis
2.6
6.2
33
127
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
3.3
6.1
22
67
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.1
774
6747
G50.1
ICD-10 Finland
Atypical facial pain
2.8
6.1
29
105
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.3
6.0
44
196
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
6.0
356
2778
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
219
849
2.86
40.09
2.6
2.5
20.62
19.88
au/ml
0.04
22
77
132
378
3.74
39.80
2.1
1.6
1.24
1.19
g/l
1.04
127
361
128
366
3.74
38.66
2.2
1.6
0.24
0.24
g/l
0.26
123
352
204
777
2.89
38.51
1.4
1.3
23.23
44.98
au/ml
—
7
57
983
7493
1.97
30.87
13.2
9.9
4.09
4.07
e9/l
0.10
872
6536
149
537
2.98
30.86
2.6
1.7
10.47
7.28
iu/ml
0.40
31
121
203
934
2.36
25.58
1.9
1.6
—
—
—
0
0
873
6609
1.81
25.58
10.0
7.4
1.22
1.21
mmol/l
0.07
800
5731
1174
9787
2.05
25.11
11.6
8.3
79.75
79.77
u/l
0.01
1129
9290
1141
9458
1.97
24.22
6.3
4.4
12.31
12.21
mm/h
0.08
1087
8850
887
6829
1.77
23.68
8.1
6.7
11.26
11.37
umol/l
0.10
849
6528
780
5806
1.74
23.30
6.7
5.1
35.73
35.72
g/l
0.01
741
5458
130
515
2.67
22.42
1.4
1.2
0.22
0.97
u/ml
0.81
11
36
272
1479
2.03
22.36
4.3
4.5
240.91
245.92
u/l
0.21
258
1413
580
4015
1.74
22.11
2.7
2.2
198.41
221.61
u/l
0.17
564
3823
876
6799
1.73
21.93
5.4
3.9
0.00
0.00
estimate
0.50
177
1419
883
6869
1.73
21.92
5.4
4.0
7.76
4.38
estimate
0.17
180
1465
300
1703
1.96
21.77
3.1
2.4
107.96
122.36
ug/g
0.50
246
1359
785
5923
1.71
21.71
8.8
6.7
1.21
1.21
mmol/l
0.13
753
5469
888
6930
1.73
21.68
5.5
4.0
0.04
0.23
estimate
0.40
173
1363
210
1053
2.16
21.34
3.1
3.1
10.30
10.75
g/l
0.63
198
977
1022
8386
1.74
19.87
6.5
4.7
3569.00
2072.70
e6/l
0.16
11
122
238
1285
2.02
19.78
2.4
2.1
339.46
382.34
nmol/l
2.83
226
1197
101
381
2.77
19.12
1.4
1.2
2.36
2.41
u/ml
—
7
34
101
382
2.77
19.03
1.4
1.2
23.19
9.65
u/ml
0.28
11
61
104
405
2.69
18.52
1.4
1.2
78.97
24.18
u/ml
—
7
18
435
2905
1.71
18.09
2.4
1.8
1.30
1.18
mg/l
0.28
339
2250
530
3744
1.65
17.73
3.7
3.1
0.00
0.02
0.49
12
86
583
4220
1.64
17.70
4.5
3.4
40.14
70.74
e6/l
0.83
447
3237
516
3642
1.65
17.20
4.5
3.2
0.30
0.45
e6/l
1.13
383
2694
471
3254
1.66
17.04
3.2
2.8
334.00
337.17
umol/l
0.27
413
2874
646
4836
1.61
16.84
5.7
4.0
91.08
109.69
e6/l
0.17
462
3406
599
4414
1.61
16.61
4.8
3.3
30.22
32.64
u/l
1.06
574
4178
85
320
2.76
16.16
1.3
1.2
59.21
54.28
u/ml
—
10
30
564
4119
1.60
16.10
3.4
2.6
54.72
61.09
u/l
1.61
519
3820
169
867
2.07
16.00
1.4
1.3
625.91
210.55
u/ml
0.77
155
801
352
2286
1.71
15.91
3.8
2.9
0.97
1.13
e6/l
0.49
188
1214
744
5815
1.57
15.76
19.1
14.5
1.28
1.24
inr
0.86
631
4848
198
1088
1.95
15.45
2.5
3.0
66.64
66.54
g/l
0.06
191
1005
161
829
2.06
15.07
1.7
1.9
1.29
1.42
g/l
0.44
148
771
912
7522
1.57
14.85
6.9
5.1
6.57
6.67
mmol/l
0.78
878
7129
613
4635
1.56
14.68
3.9
3.6
2.36
2.36
mmol/l
0.10
564
4229
325
2109
1.70
14.58
4.0
3.1
3.52
2.63
e6/l
0.64
156
1036
335
2192
1.69
14.56
2.1
1.9
—
—
—
0
0
729
5748
1.54
14.32
2.5
2.1
95.11
96.40
pmol/l
0.31
402
2979
369
2494
1.64
14.09
1.4
1.3
21.37
29.27
iu/ml
1.04
107
777
394
2717
1.62
13.84
1.6
1.5
2.22
2.40
g/l
1.26
252
1689
930
7770
1.55
13.74
3.4
3.0
—
—
—
0
0
40
111
3.68
12.64
1.3
1.1
—
—
—
0
0
747
6021
1.50
12.58
3.2
2.5
75.11
77.68
nmol/l
1.86
696
5453
45
136
3.38
12.52
1.3
1.2
—
—
—
0
0
759
6146
1.49
12.44
4.1
3.1
122.35
117.07
ug/l
0.23
714
5752
40
113
3.61
12.32
1.3
1.1
—
—
—
0
0
42
123
3.49
12.26
1.3
1.1
—
—
—
0
0
465
3412
1.53
12.20
3.1
2.3
2.67
2.84
mg/l
0.93
412
2933
211
1273
1.77
12.12
2.5
2.2
0.21
0.21
g/l
0.11
200
1191
87
382
2.36
12.07
1.3
1.3
—
—
—
0
0
98
454
2.24
12.00
2.0
1.6
—
—
—
0
0
40
116
3.52
11.86
1.3
1.1
—
—
—
0
0
40
116
3.52
11.86
1.3
1.1
—
—
—
0
0
1330
12295
1.98
11.83
26.5
15.9
21.66
23.75
mg/l
1.82
1173
10112
451
3307
1.53
11.79
6.4
4.3
91.49
90.95
%
0.16
437
3240
256
1657
1.66
11.34
2.0
1.8
—
—
—
0
0
273
1805
1.63
11.10
7.7
5.7
1.05
1.05
mmol/l
0.16
258
1663
321
2213
1.58
10.95
4.9
3.5
0.80
0.82
mmol/l
1.77
300
2094
334
2324
1.57
10.95
1.4
1.3
11.66
12.41
u/ml
0.07
117
886
612
4845
1.46
10.68
4.8
3.8
37.99
67.61
ng/l
0.72
423
3407
85
390
2.25
10.67
3.5
2.9
191.55
187.97
%
0.13
78
375
413
3036
1.50
10.44
4.8
4.0
1.02
1.52
kg/l
0.50
300
2017
318
2213
1.56
10.35
3.0
2.6
13.20
12.89
umol/l
0.32
299
2072
706
5767
1.44
10.28
16.4
11.5
0.00
0.00
e9/l
0.34
582
4696
234
1524
1.64
10.04
3.9
2.9
8.47
7.32
umol/l
0.38
199
1349
87
414
2.17
10.00
1.5
1.5
0.60
17.45
iu/ml
0.47
17
69
290
1993
1.57
9.94
2.8
2.2
29.72
29.36
s
0.44
283
1936
188
1160
1.71
9.90
3.0
2.9
71.68
70.41
e9/l
0.15
135
840
351
2525
1.51
9.75
5.0
3.9
182.52
373.72
ng/l
1.25
273
1951
239
1579
1.61
9.66
2.1
1.8
—
—
—
0
0
501
3890
1.44
9.38
3.6
3.1
1605.09
1225.72
ng/l
1.34
444
3332
276
1899
1.56
9.36
3.0
2.6
22.29
22.69
%
0.19
257
1786
1112
9966
1.50
9.36
5.7
4.5
14.93
14.78
pmol/l
1.25
1044
9182
393
2918
1.48
9.28
3.4
2.6
4.34
6.42
e6/l
2.82
364
2671
964
8419
1.43
9.20
4.7
3.3
50.76
47.19
u/l
0.57
908
7928
52
205
2.59
9.12
1.3
1.2
5.81
5.78
u/ml
0.00
26
82
293
2056
1.53
9.07
2.9
2.5
2.38
2.31
g/l
1.26
275
1915
52
210
2.53
8.70
1.3
1.2
5.24
3.83
u/ml
0.14
17
60
108
586
1.91
8.69
1.8
2.0
1.32
1.51
g/l
1.47
95
517
1337
12561
1.82
8.69
28.4
18.7
139.45
139.67
mmol/l
2.44
1321
12320
1338
12579
1.82
8.59
28.8
18.9
3.96
3.96
mmol/l
0.02
1318
12314
43
159
2.76
8.56
1.4
1.3
—
—
—
0
0
205
1342
1.61
8.55
8.3
8.3
96.29
95.48
%
1.25
199
1299
84
420
2.06
8.53
2.4
2.4
0.14
0.02
g/l
0.63
78
381
317
2300
1.48
8.29
1.7
1.5
—
—
—
0
0
35
118
3.01
8.23
1.3
1.1
44.60
81.00
u/ml
—
5
9
408
3112
1.43
8.21
1.4
1.3
1.75
1.42
u/ml
0.24
103
844
297
2131
1.50
8.20
1.8
1.7
1115.07
1173.41
nmol/l
0.61
241
1616
92
484
1.96
8.12
2.4
2.6
0.95
1.33
g/l
0.34
84
425
628
5166
1.38
8.10
5.4
3.8
0.03
0.12
estimate
0.56
144
1179
1254
11642
1.57
7.85
7.0
5.5
1.85
1.90
mu/l
0.90
1187
10804
70
338
2.13
7.80
1.5
1.6
—
—
—
0
0
477
3770
1.40
7.75
1.9
1.7
20.48
20.69
nmol/l
0.11
418
3180
191
1258
1.60
7.75
8.7
8.8
120.10
120.24
g/l
0.03
186
1229
79
401
2.03
7.72
1.4
1.4
294.92
284.92
ug/g
0.14
44
239
220
1505
1.54
7.57
8.1
7.9
1.18
0.96
mmol/l
0.33
182
1245
104
584
1.84
7.55
1.9
2.0
38.37
39.22
u/l
0.16
94
521
466
3691
1.39
7.41
5.2
3.4
0.07
0.27
estimate
0.40
148
1124
220
1512
1.54
7.40
8.1
7.9
12.33
12.29
kpa
0.04
213
1459
220
1512
1.54
7.40
8.1
8.0
5.05
5.10
kpa
0.35
214
1459
19
32
6.00
7.38
1.2
1.1
0.31
0.29
g/l
0.37
14
25
20
50
4.04
7.36
1.1
1.0
—
—
—
0
0
167
1081
1.62
7.27
4.4
3.8
80.68
85.42
ng/l
0.33
149
944
191
1279
1.57
7.21
2.7
2.3
41.82
37.71
u/l
0.25
163
1072
69
343
2.06
7.15
1.7
1.7
—
—
—
0
0
175
1151
1.59
7.13
8.3
7.4
9.58
9.50
mmol/l
0.05
167
1109
70
351
2.04
7.09
1.5
1.6
—
—
—
0
0
82
436
1.93
7.05
3.0
3.9
32.24
56.84
mg/l
1.70
72
378
51
226
2.30
7.03
1.4
1.2
49.00
321.54
titre
—
5
13
138
859
1.67
7.01
6.9
4.2
5.14
5.14
kpa
0.03
130
833
82
437
1.93
7.00
3.0
3.9
72.57
61.92
mg/l
0.15
73
377
62
299
2.12
6.96
1.3
1.7
173.72
43.96
e6/l
0.34
50
231
195
1328
1.54
6.82
6.7
4.1
1.54
1.85
mmol/l
0.68
176
1134
78
413
1.94
6.79
2.4
2.4
0.00
0.00
g/l
-0.00
72
363
62
302
2.10
6.79
1.4
1.8
954.91
556.58
e6/l
0.16
53
240
69
351
2.01
6.74
1.2
1.1
—
—
—
0
0
76
401
1.94
6.69
1.3
1.3
—
—
—
0
0
28
94
3.02
6.67
1.1
1.0
—
—
—
0
0
30
105
2.90
6.65
1.1
1.1
26.86
40.80
mg/l
1.75
22
86
153
991
1.61
6.65
2.5
3.0
163.25
200.70
ng/l
0.66
144
903
29
100
2.94
6.60
1.1
1.1
386.04
257.63
mg/l
0.39
24
84
200
1380
1.52
6.58
6.8
4.0
5.78
5.81
kpa
0.18
194
1340
467
3758
1.36
6.57
5.9
4.0
0.00
0.01
estimate
1.54
166
1335
24
74
3.28
6.57
1.0
1.1
—
—
—
0
0
17
41
4.18
6.56
1.8
1.4
10.12
8.71
ug/l
0.36
17
41
701
5995
1.33
6.52
3.5
2.8
—
—
estimate
—
0
0
1260
11828
1.50
6.23
23.6
15.4
81.30
80.88
ml/min/173m2
0.29
1170
10929
67
350
1.96
6.10
1.2
1.1
—
—
—
0
0
29
105
2.80
6.07
1.3
1.1
320.00
97.14
titre
—
10
14
33
128
2.61
6.07
1.1
1.6
—
—
—
0
0
24
79
3.07
5.93
1.3
1.2
—
—
—
0
0
126
805
1.62
5.80
1.9
1.7
—
—
—
0
0
25
87
2.91
5.63
2.7
2.8
—
—
—
0
0
21
66
3.21
5.60
1.2
1.1
—
—
—
0
0
147
983
1.55
5.58
1.4
1.4
—
—
—
0
0
53
263
2.05
5.58
5.7
5.6
23997.00
335.82
iu/ml
—
6
33
39
171
2.32
5.56
1.6
1.7
—
—
—
0
0
45
210
2.18
5.55
3.4
3.1
728.33
613.93
u/ml
—
6
14
47
224
2.13
5.50
1.6
1.7
—
—
—
0
0
60
314
1.95
5.46
1.3
1.5
3.66
3.71
mmol/l
0.13
54
298
1360
13045
1.68
5.45
31.4
20.7
75.78
75.64
umol/l
0.06
1349
12903
71
395
1.84
5.38
2.9
3.7
1.72
3.31
ratio
0.95
43
225
116
742
1.61
5.33
7.6
4.1
1.81
1.92
mmol/l
0.14
84
560
66
360
1.87
5.32
3.4
3.2
1.10
2.03
index
1.00
41
185
42
194
2.20
5.32
1.1
1.1
—
—
—
0
0
72
404
1.82
5.31
1.8
2.1
81.56
4010.26
u/l
2.59
18
167
41
188
2.22
5.28
2.5
1.8
1.75
1.72
mmol/l
0.08
41
183
1350
12940
1.62
5.24
17.8
12.2
26.10
25.45
u/l
0.73
1326
12584
535
4504
1.30
5.22
4.0
3.4
6.86
7.33
mmol/l
1.68
461
3833
79
462
1.75
5.09
2.7
2.3
369.63
365.63
ug/l
0.01
73
436
338
2677
1.34
5.09
2.9
2.9
2.46
2.46
mmol/l
0.43
305
2424
121
791
1.58
5.08
2.9
3.6
4.34
4.52
pmol/l
1.13
109
702
10
12
8.38
5.06
3.6
1.1
—
—
—
0
0
392
3177
1.32
5.03
3.3
2.4
—
—
—
0
0
50
253
2.01
5.02
1.4
1.4
—
—
—
0
0
50
253
2.01
5.02
1.4
1.4
—
—
—
0
0
30
123
2.47
4.98
2.0
1.1
—
—
—
0
0
100
631
1.63
4.87
1.4
1.4
25.79
28.17
iu/l
0.30
82
541
25
95
2.66
4.83
1.8
1.6
—
—
—
0
0
127
851
1.54
4.80
9.5
9.6
94.22
93.81
%
0.34
127
846
50
258
1.97
4.77
1.4
1.5
—
—
—
0
0
163
1154
1.46
4.73
6.6
3.6
4.58
4.52
kpa
0.17
157
1119
71
412
1.76
4.72
1.5
1.3
—
—
—
0
0
123
825
1.54
4.63
9.5
9.7
0.60
0.64
%
0.47
123
820
60
333
1.84
4.62
1.5
1.5
11.77
9.94
u/l
0.39
48
257
123
826
1.53
4.61
2.7
2.3
12.49
12.84
nmol/l
0.17
110
752
95
602
1.62
4.56
6.1
5.6
1.67
1.56
%
0.52
89
569
1110
10346
1.31
4.50
32.9
20.7
331.73
331.94
g/l
0.32
1104
10290
17
54
3.17
4.49
1.3
2.6
21.66
169.22
ug/l
0.49
17
47
25
99
2.55
4.47
1.4
1.1
—
43.20
—
0
5
153
1082
1.46
4.47
2.4
2.4
0.22
0.46
e6/l
1.49
143
1036
32
143
2.27
4.43
1.3
1.2
—
—
—
0
0
35
163
2.18
4.39
1.6
1.6
—
—
—
0
0
22
83
2.68
4.33
1.0
1.1
0.99
1.09
u/l
—
7
41
22
83
2.68
4.33
1.3
1.2
0.50
0.54
ratio
0.53
11
51
99
643
1.58
4.31
1.3
1.3
—
—
—
0
0
125
862
1.49
4.15
9.5
9.4
1.43
1.29
%
0.66
125
856
56
316
1.80
4.12
1.4
1.5
—
—
—
0
0
196
1474
1.38
4.07
1.7
1.8
1.40
1.47
%
0.86
168
1296
83
525
1.62
4.05
1.8
1.9
2.78
1.82
ug/l
0.43
70
469
14
42
3.36
4.05
1.4
1.1
—
—
—
0
0
33
156
2.14
4.02
1.4
1.3
0.19
0.18
nmol/l
0.34
28
121
25
105
2.41
3.99
1.1
1.3
0.57
1.34
u/ml
0.57
18
51
1246
11861
1.36
3.98
5.7
5.1
5.93
5.92
mmol/l
0.06
1168
10895
20
76
2.65
3.90
1.4
1.9
—
—
—
0
0
20
76
2.65
3.90
1.4
1.9
—
—
—
0
0
31
145
2.16
3.88
2.3
2.4
17.00
28.60
mg/l
—
9
60
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
399
1.69
3.84
3.1
2.9
0.36
0.36
iu/ml
0.01
30
215
32
153
2.12
3.80
1.3
1.3
—
—
—
0
0
32
153
2.12
3.80
1.3
1.3
—
—
—
0
0
1219
11584
1.33
3.79
7.4
6.4
39.24
39.22
mmol/mol
0.03
1159
10861
182
1370
1.38
3.76
3.7
4.4
12.91
23.32
ug/l
0.43
150
1116
46
252
1.85
3.74
1.7
1.2
251.00
268.49
u/ml
0.16
25
148
32
154
2.10
3.74
1.3
1.3
—
—
—
0
0
33
161
2.07
3.73
1.3
1.3
—
—
—
0
0
12
29
4.16
3.70
1.3
1.2
—
—
—
0
0
47
261
1.83
3.67
1.4
1.5
—
—
—
0
0
58
343
1.72
3.67
1.7
1.6
30837.50
12873.02
e6/l
0.47
36
245
30
142
2.14
3.66
1.0
1.1
—
—
—
0
0
50
285
1.78
3.60
1.8
1.6
—
—
—
0
0
605
5342
1.23
3.56
2.1
1.9
1.37
1.34
mmol/l
0.27
514
4548
32
158
2.05
3.52
1.3
1.3
—
—
—
0
0
21
87
2.43
3.48
1.5
1.2
—
—
—
0
0
39
210
1.88
3.37
1.5
1.5
—
—
—
0
0
31
154
2.04
3.36
1.7
1.9
—
2146.67
—
0
6
32
161
2.01
3.36
1.3
1.3
—
—
—
0
0
33
169
1.97
3.30
1.7
1.3
—
—
—
0
0
18
71
2.55
3.30
1.1
1.2
—
—
—
0
0
18
71
2.55
3.30
1.1
1.2
—
—
—
0
0
40
219
1.85
3.29
1.4
1.7
—
—
—
0
0
33
170
1.96
3.25
1.6
1.7
24.36
31.39
ng/l
0.41
33
170
1375
13381
1.53
3.24
38.3
24.3
255.24
253.43
e9/l
0.47
1360
13119
1281
12316
1.34
3.24
6.5
5.8
2.69
2.72
mmol/l
0.72
1211
11472
23
103
2.25
3.23
1.0
1.0
—
—
—
0
0
19
78
2.45
3.22
1.8
1.4
—
—
—
0
0
1260
12089
1.32
3.20
5.6
5.0
1.47
1.49
mmol/l
1.23
1188
11233
1375
13384
1.52
3.20
38.1
24.2
91.16
91.06
fl
0.37
1368
13244
52
311
1.70
3.20
1.4
1.8
—
—
—
0
0
66
420
1.60
3.20
2.9
3.8
1.36
1.32
mmol/l
0.10
66
413
1375
13387
1.52
3.16
38.2
24.3
4.43
4.46
e12/l
1.51
1359
13087
1375
13387
1.52
3.16
38.9
24.8
39.72
40.43
%
1.28
1368
13239
1375
13388
1.52
3.15
38.2
24.3
6.84
6.70
e9/l
1.16
1358
13083
1375
13391
1.51
3.11
38.6
24.5
133.13
134.26
g/l
2.15
1369
13251
56
345
1.65
3.09
1.2
1.1
3.27
4.25
—
7
43
20
86
2.34
3.08
1.5
1.2
—
—
—
0
0
39
217
1.82
3.07
1.2
1.3
—
—
—
0
0
15
56
2.70
3.06
4.1
3.3
1157.87
936.36
u/ml
0.16
15
56
6
8
7.53
3.05
3.7
5.4
—
—
—
0
0
18
74
2.45
3.05
1.8
1.4
—
—
—
0
0
51
308
1.68
3.04
2.7
2.1
129.17
129.81
g/l
0.07
41
251
1264
12150
1.31
3.03
5.8
5.1
4.60
4.67
mmol/l
1.91
1200
11361
9
21
4.31
2.99
1.0
1.0
—
—
—
0
0
59
372
1.61
2.99
1.3
1.3
—
—
—
0
0
71
468
1.54
2.98
2.1
1.9
—
—
—
0
0
20
88
2.29
2.94
1.7
1.4
—
—
—
0
0
489
4293
1.21
2.91
4.5
4.1
9.59
8.62
mg/mmol
0.20
298
2648
21
95
2.23
2.90
1.9
1.8
—
—
—
0
0
39
222
1.78
2.87
1.2
1.1
2.45
5.04
u/ml
1.07
26
108
63
411
1.56
2.78
1.4
1.3
263.25
238.30
miu/ml
0.14
18
194
25
124
2.03
2.77
1.1
1.1
—
—
—
0
0
65
428
1.54
2.76
2.2
1.8
—
—
—
0
0
5
6
8.36
2.75
1.2
1.2
1.80
1.00
u/field
—
5
6
124
926
1.37
2.74
1.2
1.2
107.41
146.62
u/ml
0.56
47
349
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
72
2.38
2.73
1.1
1.2
—
—
—
0
0
16
66
2.44
2.71
3.5
1.5
—
—
—
0
0
95
679
1.43
2.70
1.6
1.5
—
—
—
0
0
65
431
1.53
2.68
2.3
2.8
—
—
—
0
0
21
100
2.12
2.59
1.8
1.4
—
—
—
0
0
8
20
4.02
2.57
2.5
1.5
—
—
—
0
0
154
1202
1.31
2.55
2.5
2.0
—
—
—
0
0
15
62
2.43
2.54
1.2
1.5
—
—
—
0
0
15
62
2.43
2.54
1.2
1.5
—
—
—
0
0
15
62
2.43
2.54
1.2
1.5
—
—
—
0
0
15
62
2.43
2.54
1.2
1.5
—
—
—
0
0
71
486
1.48
2.54
10.4
4.8
24.67
24.91
mmol/l
0.42
65
453
61
405
1.53
2.52
6.4
4.8
1.66
1.49
mg/l
0.71
56
371
22
108
2.05
2.52
1.3
1.5
—
—
—
0
0
22
108
2.05
2.52
1.3
1.5
—
—
—
0
0
22
108
2.05
2.52
1.3
1.5
—
—
—
0
0
11
37
2.99
2.49
1.4
1.1
—
—
—
0
0
166
1314
1.30
2.48
2.6
2.1
—
—
—
0
0
19
89
2.15
2.45
1.8
1.4
—
—
—
0
0
282
2385
1.23
2.40
5.4
4.6
21.16
21.18
%
0.01
131
1143
55
362
1.54
2.38
1.5
1.4
—
—
—
0
0
8
22
3.65
2.36
1.1
1.1
83.38
95.27
%
—
8
22
12
46
2.62
2.36
1.1
1.2
78.83
86.57
%
—
6
23
16
71
2.27
2.34
1.3
1.1
—
—
—
0
0
42
262
1.62
2.28
1.1
1.1
2.60
2.26
u/ml
0.08
27
141
43
270
1.61
2.28
9.0
8.4
105.71
105.22
mmol/l
0.30
38
244
12
47
2.57
2.27
1.1
1.7
81.50
87.32
%
—
6
25
43
272
1.60
2.22
1.4
1.5
—
—
—
0
0
35
210
1.68
2.21
1.1
1.1
0.59
1.77
u/ml
1.51
24
104
1201
11567
1.22
2.21
4.8
4.3
1.32
1.28
mmol/l
1.05
1119
10645
18
87
2.08
2.17
2.6
2.6
436.00
571.19
e6/l
0.46
13
70
18
88
2.06
2.11
2.7
2.7
176.23
235.13
e6/l
1.07
13
76
69
491
1.43
2.07
1.6
1.7
25.29
11.13
u/ml
—
9
108
38
238
1.61
2.06
1.8
1.4
148.95
156.40
au/ml
0.15
13
66
31
184
1.70
2.05
1.4
1.3
31.47
28.29
u/l
0.15
26
150
341
2982
1.19
2.04
6.0
5.5
2.33
2.46
ug/l
0.16
309
2670
160
1297
1.26
2.01
4.4
3.3
—
—
—
0
0
55
379
1.47
1.96
1.6
1.9
1.77
19.87
iu/l
0.61
21
150
12
52
2.32
1.88
4.2
4.2
—
—
—
0
0
24
136
1.78
1.88
1.5
2.2
0.06
0.85
mmol/l
0.77
24
130
99
762
1.32
1.86
2.8
2.1
—
—
—
0
0
11
46
2.40
1.85
1.2
1.7
39.64
88.15
nmol/24h
2.31
11
46
29
175
1.67
1.83
1.1
1.1
1.78
6.39
u/ml
1.59
14
74
7
24
2.93
1.72
1.0
1.1
—
—
—
0
0
51
357
1.44
1.71
1.3
1.2
—
—
—
0
0
16
82
1.96
1.70
1.2
1.4
11.75
13.06
u/l
0.44
16
77
24
141
1.71
1.68
2.0
1.7
—
—
—
0
0
22
126
1.76
1.68
2.1
1.7
—
—
—
0
0
12
55
2.19
1.67
1.2
1.2
5.68
4.94
umol/l
0.19
12
49
18
98
1.85
1.62
1.1
1.1
4.28
11.45
iu/ml
—
5
26
12
56
2.15
1.61
1.0
1.2
—
—
—
0
0
12
56
2.15
1.61
1.0
1.2
—
—
—
0
0
8
32
2.51
1.59
1.0
1.2
—
—
—
0
0
14
70
2.01
1.59
1.3
1.1
—
—
—
0
0
306
2706
1.17
1.59
1.8
1.7
31203469.13
27467101.20
pmol/l
0.04
266
2250
10
43
2.33
1.59
1.2
1.1
—
—
—
0
0
6
20
3.01
1.58
1.8
1.4
—
—
—
0
0
25
152
1.66
1.57
2.3
1.5
—
—
—
0
0
36
240
1.51
1.55
11.9
4.1
2.85
2.77
mmol/l
0.06
30
159
21
122
1.73
1.55
2.0
2.3
—
—
—
0
0
82
635
1.31
1.52
2.5
2.0
—
—
—
0
0
12
58
2.08
1.49
1.2
1.4
156.38
171.15
pmol/l
0.16
12
58
10
45
2.23
1.46
1.2
1.0
—
—
—
0
0
69
526
1.33
1.44
1.6
1.6
0.41
0.33
mg/l
0.25
26
242
12
59
2.04
1.43
1.0
1.1
107.31
198.63
iu/ml
1.12
12
59
6
22
2.73
1.43
1.5
1.1
—
—
—
0
0
29
188
1.55
1.43
1.1
1.1
1.28
3.77
u/ml
1.77
16
90
126
1038
1.23
1.43
8.3
3.8
1.23
1.23
mmol/l
0.07
118
888
28
181
1.56
1.40
1.3
1.2
—
—
—
0
0
125
1033
1.23
1.38
2.1
2.4
6.25
7.75
ug/l
0.56
103
920
25
158
1.59
1.38
1.1
1.1
0.10
0.46
u/ml
1.10
12
50
9
43
2.10
1.30
1.6
1.3
—
—
—
0
0
204
1777
1.17
1.30
3.3
3.3
0.76
0.77
ug/l
0.06
129
1155
13
69
1.89
1.28
1.1
1.1
1552.47
1631.74
miu/ml
0.13
13
69
25
162
1.55
1.26
1.2
1.1
—
—
—
0
0
34
236
1.45
1.25
1.1
1.1
33.98
17.68
au/ml
—
9
65
25
163
1.54
1.23
1.1
1.5
273.53
276.36
mosm/kgh2o
0.26
17
119
10
49
2.05
1.22
1.3
1.6
—
—
—
0
0
10
49
2.05
1.22
1.3
1.6
—
—
—
0
0
244
2172
1.15
1.18
1.6
1.5
—
—
—
0
0
85
688
1.25
1.17
1.1
1.0
—
—
—
0
0
10
50
2.01
1.16
1.3
1.6
—
—
—
0
0
19
119
1.60
1.12
1.2
1.4
21312.00
90715.59
e6/l
0.63
11
63
65
514
1.28
1.09
2.9
3.4
467.63
2920.45
u/ml
0.69
52
454
12
66
1.83
1.09
1.2
1.7
0.83
4.99
u/field
0.90
12
48
111
1313
0.83
1.08
2.1
2.0
3.71
3.46
ratio
0.98
89
1026
13
74
1.76
1.07
3.5
3.1
0.62
0.81
index
0.63
13
74
17
105
1.63
1.06
1.1
2.1
1.45
1.84
u/field
0.23
11
57
7
33
2.13
1.05
1.0
1.0
—
—
—
0
0
9
46
1.96
1.03
1.0
1.4
—
—
—
0
0
7
35
2.00
1.00
1.6
2.8
4.71
5.51
ug/l
—
7
35
6
27
2.23
0.93
2.5
2.6
17.18
18.53
umol/l
—
6
27
11
63
1.75
0.90
1.0
1.9
—
—
—
0
0
6
30
2.00
0.87
1.0
1.0
27.00
51.43
iu/ml
—
6
30
12
72
1.67
0.85
5.3
1.5
32.30
29.68
umol/l
0.42
12
65
6
32
1.88
0.82
1.0
1.5
—
—
—
0
0
35
267
1.32
0.81
3.8
3.5
0.94
0.82
nmol/l
0.29
29
227
10
58
1.73
0.79
1.0
1.1
—
—
—
0
0
31
407
0.76
0.79
1.1
1.1
0.50
0.67
ratio
—
5
53
36
458
0.78
0.74
1.2
1.2
0.85
0.90
g/l
0.57
36
458
9
57
1.58
0.71
3.1
1.6
—
1020533.17
—
0
6
17
118
1.45
0.69
1.2
1.1
119.53
107.43
pmol/l
0.40
17
118
35
275
1.28
0.68
2.4
2.4
44.37
100.28
ug/min
1.03
20
169
7
42
1.67
0.68
8.7
3.0
9.81
10.38
kpa
—
7
42
7
42
1.67
0.68
8.7
3.0
5.75
4.69
kpa
—
7
42
35
440
0.79
0.67
1.1
1.1
1.54
1.55
g/l
0.13
35
440
44
357
1.24
0.67
1.1
1.1
2.53
6.98
eliau/ml
—
6
41
7
43
1.63
0.67
2.1
1.5
—
—
—
0
0
10
64
1.57
0.58
1.1
1.3
139.80
169.45
mmol/24h
—
10
64
19
140
1.36
0.58
1.2
1.4
2083.46
1840.95
e6/l
0.10
13
93
12
81
1.49
0.57
1.1
1.8
106.08
105.94
ng/l
0.00
12
81
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
156
1426
1.11
0.55
7.2
6.8
—
—
—
0
0
9
62
1.45
0.53
3.9
4.1
2.22
1.06
%
—
9
62
87
969
0.89
0.46
1.7
1.7
3.68
3.49
mmol/l
0.98
63
683
76
677
1.13
0.44
4.2
3.5
1.02
1.02
ratio
0.91
70
627
7
51
1.37
0.44
1.7
2.0
37.91
40.21
g/l
—
7
51
33
275
1.20
0.43
1.5
1.7
0.83
0.89
nmol/l
0.19
28
232
19
240
0.79
0.42
1.5
1.5
0.95
0.94
ratio
0.06
13
151
19
240
0.79
0.42
1.5
1.5
1.02
1.15
ratio
0.39
13
151
19
240
0.79
0.42
1.5
1.5
1.03
1.20
ratio
0.38
13
151
8
59
1.36
0.41
1.6
1.2
6.50
10.25
mm/h
—
8
59
5
34
1.47
0.40
2.2
1.3
0.29
0.34
ug/l
—
5
25
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
17
214
0.79
0.38
1.6
1.6
—
—
—
0
0
19
235
0.81
0.37
1.5
1.5
—
—
—
0
0
10
72
1.39
0.37
14.0
12.3
0.59
0.63
mmol/l
—
10
67
23
189
1.22
0.36
1.2
1.1
1.67
1.96
eliau/ml
—
9
77
164
1545
1.07
0.33
5.3
4.9
32.90
32.57
%
0.14
113
1027
20
164
1.22
0.32
1.7
2.5
32.55
32.74
pg
0.07
20
164
21
174
1.21
0.31
1.0
1.1
—
—
—
0
0
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
8
64
1.25
0.27
1.0
1.2
—
—
—
0
0
16
191
0.84
0.24
2.2
1.7
—
—
—
0
0
43
474
0.90
0.23
1.6
1.8
2.72
5.26
mg/l
1.15
35
360
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
11
90
1.22
0.19
1.1
1.2
7.91
11.83
u/l
1.95
11
80
29
261
1.11
0.18
3.0
3.7
28.13
25.82
mg/l
0.14
21
184
15
130
1.16
0.15
1.5
1.3
13390.00
177599.08
e6/l
—
7
89
33
304
1.09
0.14
1.2
1.5
—
—
—
0
0
23
212
1.09
0.10
1.3
1.1
1.40
155.36
iu/ml
—
5
47
5
61
0.82
0.08
4.6
2.5
60.20
49.44
umol/l
—
5
51
5
63
0.79
0.08
3.0
2.5
—
—
—
0
0
45
431
1.05
0.07
1.6
1.5
—
—
—
0
0
7
85
0.82
0.07
1.3
1.4
70.86
78.62
umol/l
—
7
85
105
1027
1.02
0.06
4.3
2.7
64.31
66.54
ml/min/173m2
0.21
49
443
16
149
1.07
0.05
2.1
1.6
47.69
59.38
%
0.66
11
97
10
107
0.93
0.02
1.0
1.1
284.60
285.16
mg/l
—
10
94
19
184
1.03
0.00
1.0
1.1
1.50
1.51
g/l
0.03
19
169
16
158
1.01
0.00
1.3
1.5
62.43
52.79
ug/l
0.59
16
158
12
121
0.99
0.00
1.7
1.7
—
—
—
0
0
13
133
0.98
0.00
2.7
3.8
—
—
—
0
0
48
475
1.01
0.00
1.6
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
20.82
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
2.83
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
1.63
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
38.36
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
0.00
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
-0.00
1.7
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
85
0.94
-0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
7.76
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_ERYTHEMATOUSOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_ERYTHEMATOUSOTH | 1.367 [1.2, 1.56] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.795 |
During the follow-up period (1.1.1998 — 31.12.2019), 596 out of 3698 females with L12_ERYTHEMATOUSOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_ERYTHEMATOUSOTH | 1.759 [1.44, 2.15] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 388 out of 2261 males with L12_ERYTHEMATOUSOTH died.
Mortality risk
Mortality risk for people of age
years, who have L12_ERYTHEMATOUSOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.153% | 0.311% |
| 5 | 0.941% | 1.697% |
| 10 | 2.352% | 4.431% |
| 15 | 4.349% | 8.339% |
| 20 | 7.553% | 13.454% |
Relationships between endpoints
↥Index endpoint: L12_ERYTHEMATOUSOTH – Other erythematous conditions
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data